Superworth

Encompass Health price to sales ratio EHC

Market value divided by revenue over the last twelve months, since 2011.

Today, Oct 23, 2026
2.0×
10-year median
1.3×
Against its 10-year history
93rd
percentile: 0 is its lowest day, 100 its highest
10-year range
0.8× to 2.3×
Peer median
1.6×

Encompass Health's price to sales ratio is 2.0× as of Oct 23, 2026.

That is above its ten-year median of 1.3×, higher than on 93% of days in the last ten years.

Over that time it ranged from 0.8× in Jan 2017 to 2.3× in Sep 2025.

The median for 10 hospital and care facility stocks of a similar size is 1.6×.

Price to sales ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far2.0×1.6×2.0×
20251.9×1.8×2.3×
20241.8×1.5×2.0×
20231.4×1.2×1.6×
20221.2×0.9×1.2×
20211.0×0.9×1.5×
20201.4×0.9×1.4×
20191.2×1.1×1.3×
20181.1×1.0×1.6×
20171.0×0.8×1.0×
20160.8×0.8×0.9×
20150.9×0.8×1.4×
20141.2×1.0×1.2×
20131.0×0.8×1.1×
20120.7×0.6×0.9×
20110.6×0.5×1.0×

Against its peers

Companies in Medical - Care Facilities nearest Encompass Health's size, closest first, today.

CompanyPrice to sales ratio
EHCEncompass Health2.0×
BTSGBrightSpring Health Services0.8×
DVADavita0.8×
UHSUniversal Health Services0.6×
ENSGEnsign1.9×
PACSPACS1.4×
THCTenet Healthcare1.0×
CHEChemed2.6×
SHCSotera Health4.2×
CONConcentra Group Holdings Parent2.2×
LFSTLifeStance Health3.1×
Peer median1.6×

Where Encompass Health ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Encompass Health

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.